Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells

Immunology and Cell Biology

Volumn 89, Issue 4, 2011, Pages 558-565

  Infantes, Susana ^a   Lorente, Elena ^a   Cragnolini, Juan José ^b   Ramos, Manuel ^a   García, Ruth ^a   Jiménez, Mercedes ^a   Iborra, Salvador ^a   Del Val, Margarita ^a,b   López, Daniel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

antigen processing; mass spectrometry; MHC class I; vaccine; virus

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA CW4 CLASS 1; MATRIX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; PROTEIN CONFORMATION; PROTEOMICS; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-C ANTIGENS; HUMANS; LIGANDS; MICE; MOLECULAR DYNAMICS SIMULATION; OLIGOPEPTIDES; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

HUMAN RESPIRATORY SYNCYTIAL VIRUS;

EID: 79955771884     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.125     Document Type: Article

References (63)

1. Shastri N, Schwab S, Serwold T. Producing nature's gene-chips: the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 2002; 20: 463-493. (Pubitemid 34293432)
2. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994; 152: 163-175.
3. Rammensee HG, Bachmann J, Emmerich NPN, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999; 50: 213-219. (Pubitemid 30099526)
4. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506-512. (Pubitemid 17131093)
5. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987; 329: 512-518. (Pubitemid 17131094)
6. York IA, Goldberg AL, Mo XY, Rock KL. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol Rev 1999; 172: 49-66. (Pubitemid 30000468)
7. Collins PL, Chanock RM, Murphy BR (eds). Respiratory syncytial virus. In: Fields Virology. Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2007, pp 1443-1486.
8. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344: 1917-1928. (Pubitemid 32553362)
9. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis 2001; 183: 16-22. (Pubitemid 32043037)
10. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289: 179-186. (Pubitemid 36068705)
11. Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10: 224-231. (Pubitemid 26007454)
12. Ison MG, Hayden FG. Viral infections in immunocompromised patients: what's new with respiratory viruses? Curr Opin Infect Dis 2002; 15: 355-367. (Pubitemid 34816423)
13. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179: 25-30. (Pubitemid 29028334)
14. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352: 1749-1759. (Pubitemid 40570923)
15. Anderson LJ, Heilman CA. Protective and disease-enhancing immune responses to respiratory syncytial virus. J Infect Dis 1995; 171: 1-7.
16. Brandenburg AH, de Waal L, Timmerman HH, Hoogerhout P, de Swart RL, Osterhaus AD. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol 2000; 74: 10240-10244.
17. Rock MT, Crowe JE. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology 2003; 108: 474-480. (Pubitemid 36469685)
18. Venter M, Rock M, Puren AJ, Tiemessen CT, Crowe Jr JE. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol 2003; 77: 7319-7329. (Pubitemid 36734500)
19. Heidema J, de Bree GJ, De Graaff PM, van Maren WW, Hoogerhout P, Out TA et al. Human CD8(+) T cell responses against five newly identified respiratory syncytial virusderived epitopes. J Gen Virol 2004; 85: 2365-2374. (Pubitemid 39162609)
20. Terrosi C, Di Genova G, Savellini GG, Correale P, Blardi P, Cusi MG. Immunological characterization of respiratory syncytial virus N protein epitopes recognized by human cytotoxic T lymphocytes. Viral Immunol 2007; 20: 399-406. (Pubitemid 47585322)
21. Samino Y, López D, Guil S, de León P, Del Val M. An endogenous HIV envelope-derived peptide without the terminal NH3+ group is physiologically presented by major histocompatibility class I molecules. J Biol Chem 2004; 279: 1151-1160. (Pubitemid 38082637)
22. Samino Y, López D, Guil S, Saveanu L, van Endert PM, Del Val M. A long N-terminalextended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J Biol Chem 2006; 281: 6358-6365. (Pubitemid 43847567)
23. Meiring HD, Soethout EC, Poelen MC, Mooibroek D, Hoogerbrugge R, Timmermans H et al. Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection. Mol Cell Proteomics 2006; 5: 902-913. (Pubitemid 43792799)
24. Cragnolini JJ, Lopez de Castro JA. Identification of endogenously presented peptides from Chlamydia trachomatis with high homology to human proteins and to a natural self-ligand of HLA-B27. Mol Cell Proteomics 2008; 7: 170-180. (Pubitemid 351248242)
25. Cragnolini JJ, Garcia-Medel N, Lopez de Castro JA. Endogenous processing and presentation of T-cell Epitopes from chlamydia trachomatis with relevance in HLAB27- associated reactive arthritis. Mol Cell Proteomics 2009; 8: 1850-1859.
26. Bangham CR, McMichael AJ. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci USA 1986; 83: 9183-9187. (Pubitemid 17223559)
27. Lopez de Castro JA, Alvarez I, Marcilla M, Paradela A, Ramos M, Sesma L et al. HLA-B27: a registry of constitutive peptide ligands. Tissue Antigens 2004; 63: 424-445. (Pubitemid 38648208)
28. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987; 138: 1657-1659. (Pubitemid 17040782)
29. Zemmour J, Little AM, Schendel DJ, Parham P. The HLA-A,B 'negative' mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 1992; 148: 1941-1948.
30. Falk K, Rotzschke O, Grahovac B, Schendel D, Stevanović S, Gnau V et al. Allelespecific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA 1993; 90: 12005-12009. (Pubitemid 24008769)
31. Buchsbaum S, Barnea E, Dassau L, Beer I, Milner E, Admon A. Large-scale analysis of HLA peptides presented by HLA-Cw4. Immunogenetics 2003; 55: 172-176. (Pubitemid 36819364)
32. Rutigliano JA, Rock MT, Johnson AK, Crowe Jr JE, Graham BS. Identification of an H- 2D(b)-restricted CD8+cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus. Virology 2005; 337: 335-343. (Pubitemid 40799001)
33. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991; 351: 290-296. (Pubitemid 21896578)
34. Fan QR, Wiley DC. Structure of human histocompatibility leukocyte antigen (HLA)- Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor. J Exp Med 1999; 190: 113-123. (Pubitemid 29330128)
35. Garcia AM, Ortiz-Navarrete VF, Mora-Garcia ML, Flores-Borja F, Diaz-Quiñonez A, Isibasi-Araujo A et al. Identification of peptides presented by HLA class I molecules on cervical cancer cells with HPV-18 infection. Immunol Lett 1999; 67: 167-177. (Pubitemid 29219761)
36. Johnson RP, Trocha A, Buchanan TM, Walker BD. Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J Virol 1993; 67: 438-445. (Pubitemid 23003007)
37. Stratov I, Dale CJ, Chea S, McCluskey J, Kent SJ. Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1. J Virol 2005; 79: 7728-7737. (Pubitemid 40756806)
38. Hickman-Miller HD, Bardet W, Gilb A, Luis AD, Jackson KW, Watkins DI et al. Rhesus macaque MHC class I molecules present HLA-B-like peptides. J Immunol 2005; 175: 367-375. (Pubitemid 40884340)
39. Sette A, Sidney J, Bui HH, del Guercio MF, Alexander J, Loffredo J et al. Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. Immunogenetics 2005; 57: 53-68. (Pubitemid 40598019)
40. Cooper S, Kowalski H, Erickson AL, Arnett K, Little AM, Walker CM et al. The presentation of a hepatitis C viral peptide by distinct major histocompatibility complex class I allotypes from two chimpanzee species. J Exp Med 1996; 183: 663-668. (Pubitemid 26059525)
41. Yagüe J, Marina A, Vázquez J, López de Castro JA. Major histocompatibility complex class I molecules bind natural peptide ligands lacking the amino-terminal binding residue in vivo. J Biol Chem 2001; 276: 43699-43707.
42. Calvo V, Rojo S, Lopez D, Galocha B, Lopez DCJ. Structure and diversity of HLA-B27- specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990; 144: 4038-4045. (Pubitemid 20171221)
43. Ljunggren HG, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism. J Exp Med 1985; 162: 1745-1759. (Pubitemid 16149673)
44. Anderson KS, Alexander J, Wei M, Cresswell P. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J Immunol 1993; 151: 3407-3419. (Pubitemid 23282653)
45. Villadangos JA, Galocha B, Lopez de Castro JA. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J Immunol 1994; 152: 2317-2323. (Pubitemid 24097922)
46. Kubo H, Ikeda-Moore Y, Kikuchi A, Miwa K, Nokihara K, Schönbach C et al. Residue 116 determines the C-terminal anchor residue of HLA- B*3501 and -B*5101 binding peptides but does not explain the general affinity difference. Immunogenetics 1998; 47: 256-263. (Pubitemid 28059528)
47. Rajagopalan S, Long EO. The direct binding of a P58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-CW4 exhibits peptide selectivity. J Exp Med 1997; 185: 1523-1528. (Pubitemid 27187611)
48. Ozato K, Mayer NM, Sachs DH. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation 1982; 34: 113-120.
49. Barnstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978; 14: 9-20. (Pubitemid 8340429)
50. Parham P, Bodmer WF. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 1978; 276: 397-399. (Pubitemid 9096470)
51. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigen by a monoclonal antibody. Hum Immunol 1982; 5: 49-59. (Pubitemid 13130675)
52. López D, Calero O, Jiménez M, García-Calvo M, Del Val M. Antigen processing of a short viral antigen by proteasomes. J Biol Chem 2006; 281: 30315-30318. (Pubitemid 44582084)
53. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992; 255: 1261-1263.
54. Wang M, Lamberth K, Harndahl M, Røder G, Stryhn A, Larsen MV et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007; 25: 2823-2831. (Pubitemid 46420615)
55. Burrows SR, Gardner J, Khanna R, Steward T, Moss DJ, Rodda S et al. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J Gen Virol 1994; 75 (Part 9): 2489-2493. (Pubitemid 24282270)
56. Fan QR, Garboczi DN, Winter CC, Wagtmann N, Long EO, Wiley DC. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-CW4 class I major histocompatibility complex molecule. Proc Natl Acad Sci USA 1996; 93: 7178-7183. (Pubitemid 26243522)
57. López D, Samino Y, Koszinowski UH, Del Val M. HIV envelope protein inhibits MHC class I presentation of a cytomegalovirus protective epitope. J Immunol 2001; 167: 4238-4244. (Pubitemid 32954297)
58. Gordon JC, Myers JB, Folta T, Shoja V, Heath LS, Onufriev A. H++: a server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res 2005; 33: W368-W371. (Pubitemid 44529945)
59. Anandakrishnan R, Onufriev A. Analysis of basic clustering algorithms for numerical estimation of statistical averages in biomolecules. J Comput Biol 2008; 15: 165-184. (Pubitemid 351323140)
60. Duan Y, Wu C, Chowdhury S, Lee MC, Xiong G, Zhang Wet al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 2003; 24: 1999-2012.
61. Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983; 79: 926-935.
62. Still WC, Tempczyk A, Hawley RC, Hendrickson TY. Semianalytical treatment of solvation for molecular mechanics and dynamics. J Am Chem Soc 1990; 112: 6127-6129.
63. Weiser J, Shenkin PS, Still WC. Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO). J Com Chem 2009; 20: 217-230.